BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 27344184)

  • 1. Prognostic value of amphiregulin and epiregulin mRNA expression in metastatic colorectal cancer patients.
    Jing C; Jin YH; You Z; Qiong Q; Jun Z
    Oncotarget; 2016 Aug; 7(34):55890-55899. PubMed ID: 27344184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).
    Stahler A; Heinemann V; Giessen-Jung C; Crispin A; Schalhorn A; Stintzing S; Fischer von Weikersthal L; Vehling-Kaiser U; Stauch M; Quietzsch D; Held S; von Einem JC; Holch J; Neumann J; Kirchner T; Jung A; Modest DP
    Int J Cancer; 2016 Feb; 138(3):739-46. PubMed ID: 26284333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy.
    Llovet P; Sastre J; Ortega JS; Bando I; Ferrer M; García-Alfonso P; Donnay O; Carrato A; Jiménez A; Aranda E; León A; Grávalos C; Cámara JC; Feliú J; Sanchíz B; Caldés T; Díaz-Rubio E
    Mol Diagn Ther; 2015 Dec; 19(6):397-408. PubMed ID: 26341080
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Kuramochi H; Nakajima GO; Hayashi K; Araida T; Yamamoto M
    Anticancer Res; 2019 Sep; 39(9):4729-4736. PubMed ID: 31519572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphiregulin and epiregulin mRNA expression in primary tumors predicts outcome in metastatic colorectal cancer treated with cetuximab.
    Jacobs B; De Roock W; Piessevaux H; Van Oirbeek R; Biesmans B; De Schutter J; Fieuws S; Vandesompele J; Peeters M; Van Laethem JL; Humblet Y; Pénault-Llorca F; De Hertogh G; Laurent-Puig P; Van Cutsem E; Tejpar S
    J Clin Oncol; 2009 Oct; 27(30):5068-74. PubMed ID: 19738126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.
    Lee MS; McGuffey EJ; Morris JS; Manyam G; Baladandayuthapani V; Wei W; Morris VK; Overman MJ; Maru DM; Jiang ZQ; Hamilton SR; Kopetz S
    Br J Cancer; 2016 Jun; 114(12):1352-61. PubMed ID: 27272216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic regulation of Amphiregulin and Epiregulin in colorectal cancer.
    Bormann F; Stinzing S; Tierling S; Morkel M; Markelova MR; Walter J; Weichert W; Roßner F; Kuhn N; Perner J; Dietz J; Ispasanie S; Dietel M; Schäfer R; Heinemann V; Sers C
    Int J Cancer; 2019 Feb; 144(3):569-581. PubMed ID: 30252132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies.
    Takahashi N; Iwasa S; Taniguchi H; Sasaki Y; Shoji H; Honma Y; Takashima A; Okita N; Kato K; Hamaguchi T; Shimada Y; Yamada Y
    Br J Cancer; 2016 Apr; 114(9):1003-11. PubMed ID: 27002940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases.
    Kuramochi H; Nakajima G; Kaneko Y; Nakamura A; Inoue Y; Yamamoto M; Hayashi K
    BMC Cancer; 2012 Mar; 12():88. PubMed ID: 22409860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes.
    Pentheroudakis G; Kotoula V; De Roock W; Kouvatseas G; Papakostas P; Makatsoris T; Papamichael D; Xanthakis I; Sgouros J; Televantou D; Kafiri G; Tsamandas AC; Razis E; Galani E; Bafaloukos D; Efstratiou I; Bompolaki I; Pectasides D; Pavlidis N; Tejpar S; Fountzilas G
    BMC Cancer; 2013 Feb; 13():49. PubMed ID: 23374602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab.
    Khambata-Ford S; Garrett CR; Meropol NJ; Basik M; Harbison CT; Wu S; Wong TW; Huang X; Takimoto CH; Godwin AK; Tan BR; Krishnamurthi SS; Burris HA; Poplin EA; Hidalgo M; Baselga J; Clark EA; Mauro DJ
    J Clin Oncol; 2007 Aug; 25(22):3230-7. PubMed ID: 17664471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic role of epiregulin/amphiregulin expression in recurrent/metastatic head and neck cancer treated with cetuximab.
    Kogashiwa Y; Inoue H; Kuba K; Araki R; Yasuda M; Nakahira M; Sugasawa M
    Head Neck; 2018 Nov; 40(11):2424-2431. PubMed ID: 30302873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer.
    Williams CJM; Elliott F; Sapanara N; Aghaei F; Zhang L; Muranyi A; Yan D; Bai I; Zhao Z; Shires M; Wood HM; Richman SD; Hemmings G; Hale M; Bottomley D; Galvin L; Cartlidge C; Dance S; Bacon CM; Mansfield L; Young-Zvandasara K; Sudan A; Lambert K; Bibby I; Coupland SE; Montazeri A; Kipling N; Hughes K; Cross SS; Dewdney A; Pheasey L; Leng C; Gochera T; Mangham DC; Saunders M; Pritchard M; Stott H; Mukherjee A; Ilyas M; Silverman R; Hyland G; Sculthorpe D; Thornton K; Gould I; O'Callaghan A; Brown N; Turnbull S; Shaw L; Seymour MT; West NP; Seligmann JF; Singh S; Shanmugam K; Quirke P
    Clin Cancer Res; 2023 Oct; 29(20):4153-4165. PubMed ID: 37363997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphiregulin Expression Is a Predictive Biomarker for
    Stahler A; Stintzing S; Modest DP; Ricard I; Giessen-Jung C; Kapaun C; Ivanova B; Kaiser F; Fischer von Weikersthal L; Moosmann N; Schalhorn A; Stauch M; Kiani A; Held S; Decker T; Moehler M; Neumann J; Kirchner T; Jung A; Heinemann V
    Clin Cancer Res; 2020 Dec; 26(24):6559-6567. PubMed ID: 32943459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of the prognostic and predictive power of epidermal growth factor receptor ligand levels in patients with metastatic colorectal cancer.
    Foroughi S; Hutchinson RA; Wong HL; Christie M; Batrouney A; Wong R; Lee M; Tie J; Burgess AW; Gibbs P
    Growth Factors; 2020; 38(3-4):127-136. PubMed ID: 33775193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.
    Seligmann JF; Elliott F; Richman SD; Jacobs B; Hemmings G; Brown S; Barrett JH; Tejpar S; Quirke P; Seymour MT
    JAMA Oncol; 2016 May; 2(5):633-642. PubMed ID: 26867820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial Intelligence-Assisted Amphiregulin and Epiregulin IHC Predicts Panitumumab Benefit in
    Williams CJM; Seligmann JF; Elliott F; Shires M; Richman SD; Brown S; Zhang L; Singh S; Pugh J; Xu XM; Muranyi A; Guetter C; Lorsakul A; Kurkure U; Zhao Z; Martin J; Wang X; Nguyen K; Liu WW; Yan D; West NP; Barrett JH; Barnes M; Bai I; Seymour MT; Quirke P; Shanmugam K
    Clin Cancer Res; 2021 Jun; 27(12):3422-3431. PubMed ID: 33888518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer.
    Seligmann JF; Hatch AJ; Richman SD; Elliott F; Jacobs B; Brown S; Hurwitz H; Barrett JH; Quirke P; Nixon AB; Seymour MT
    JAMA Oncol; 2018 Apr; 4(4):564-568. PubMed ID: 29075780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between serum ligands and the skin toxicity of anti-epidermal growth factor receptor antibody in metastatic colorectal cancer.
    Takahashi N; Yamada Y; Furuta K; Nagashima K; Kubo A; Sasaki Y; Shoji H; Honma Y; Iwasa S; Okita N; Takashima A; Kato K; Hamaguchi T; Shimada Y
    Cancer Sci; 2015 May; 106(5):604-10. PubMed ID: 25707609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial.
    Stintzing S; Ivanova B; Ricard I; Jung A; Kirchner T; Tannapfel A; Juette H; Hegewisch-Becker S; Arnold D; Reinacher-Schick A
    Front Oncol; 2018; 8():474. PubMed ID: 30467535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.